PL02.03 Lurbinectedin/Doxorubicin versus CAV or Topotecan in Relapsed SCLC Patients: Phase III Randomized ATLANTIS Trial
Luis Paz‐Ares, Tudor–Eliade Ciuleanu, Alejandro Navarro, András Fülöp, Sophie Cousin, Laura Bonanno, Egbert F. Smit, Alberto Chiappori, M.E. Olmedo, Ildikó Horváth, Christian Grohé, José Antonio López-Vilariño, Ramiro Manzano-Núñez, Antonio Nieto, M. Cullell, Nuno Vasco, Carmen Kahatt, Ali Zeaiter, Enric Carcereny, Jaromı́r Roubec, K. Syrigos, Gregory Lo, I. Barneto
Topics & Concepts
MedicineTopotecanDoxorubicinChemotherapyPaclitaxelOncologyInternal medicineIn vivoPhases of clinical researchCancer researchBiologyBiotechnologyLung Cancer Research StudiesPancreatic and Hepatic Oncology Research